An audit of residual cancer burden reproducibility in a UK context.

Item

http://www.wikidata.org/entity/Q39519094

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

An audit of residual cancer burden reproducibility in a UK context.

@en

An audit of residual cancer burden reproducibility in a UK context.

@nl

type

Item

label

An audit of residual cancer burden reproducibility in a UK context.

@en

An audit of residual cancer burden reproducibility in a UK context.

@nl

prefLabel

An audit of residual cancer burden reproducibility in a UK context.

@en

An audit of residual cancer burden reproducibility in a UK context.

@nl

P1476

An audit of residual cancer burden reproducibility in a UK context

@en

P2093

David M Parham

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of occult metastases on survival in node-negative breast cancer.

Comparison of Pathologic Response Evaluation Systems after Anthracycline with/without Taxane-Based Neoadjuvant Chemotherapy among Different Subtypes of Breast Cancers

Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.

Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies.

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.

Nottingham Clinico-Pathological Response Index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer.

P304

217-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIS.13054

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sarah E. Pinder

Kalnisha Naidoo

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27496095

http://www.w3.org/2001/XMLSchema#string

P921

reproducibility